Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management

J Mol Med (Berl). 1999 Jan;77(1):140-3. doi: 10.1007/s001090050322.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Diabetes Mellitus, Type 1 / surgery*
  • Female
  • Graft Survival*
  • Humans
  • Immunosuppression
  • Islets of Langerhans Transplantation*
  • Kidney Transplantation
  • Male
  • Transplantation, Homologous